URGN
UroGen Pharma Ltd
41.20$
-1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 1.46 | 0.84 | 0.07 | 0.00 | 0.54 | 2.15 | 2.82 | 2.87 | 2.11 | 2.28 | |
| 0.00 | 0.00 | 0.05 | 0.00 | 0.06 | 0.11 | 0.00 | 0.05 | 0.23 | 0.34 | 0.32 | 0.21 | 0.26 | |
| 0.00 | 0.00 | -0.05 | 1.46 | 0.78 | -0.04 | 0.00 | 0.50 | 1.92 | 2.49 | 2.54 | 1.90 | 2.02 | |
| 1.10 | 1.74 | 4.57 | 0.86 | 1.92 | 2.34 | 2.40 | 2.17 | 2.13 | 2.32 | 1.58 | 1.33 | 1.39 | |
| 0.50 | 0.39 | 0.82 | 0.54 | 0.91 | 2.51 | 2.93 | 4.14 | 1.79 | 3.63 | 3.13 | 2.83 | 3.22 | |
| 1.60 | 1.89 | 5.39 | 1.40 | 2.83 | 4.86 | 5.33 | 6.31 | 6.05 | 5.95 | 4.82 | 4.16 | 4.62 | |
| -1.60 | -1.90 | -5.39 | 0.07 | -2.05 | -4.90 | -5.33 | -5.82 | -4.13 | -3.47 | -2.27 | -2.26 | -2.60 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.17 | 0.78 | 0.37 | 0.51 | 0.29 | 0.70 | |
| -1.56 | -1.95 | -5.51 | -0.16 | -2.06 | -4.79 | -5.12 | -5.74 | -4.89 | -4.74 | -3.41 | -2.89 | -3.19 | |
| 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | 0.01 | -0.22 | 0.15 | 0.06 | 0.08 | 0.14 | 0.07 | 0.00 | |
| -1.56 | -1.98 | -5.51 | -0.16 | -2.06 | -4.80 | -5.12 | -5.90 | -4.96 | -4.81 | -3.55 | -2.96 | -3.19 | |
| -1.59 | -1.89 | -5.34 | 0.08 | -2.03 | -4.87 | -5.27 | -5.72 | -4.86 | -3.34 | -2.09 | -2.22 | -2.82 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.